|
| News Advisory
Management of Hepatitis B: 2006 |
| What: |
The National Institutes of Health (NIH) will hold a workshop
on management of hepatitis B to assess the current understanding of hepatitis
B virus (HBV), as well as the course and management of the disease it causes.
Despite the availability of a highly effective and safe vaccine to prevent
hepatitis B and five different antiviral agents to treat the disease, hepatitis
B remains an important cause of disability and death from liver disease
in the United States and throughout the world. The workshop will address
current controversies in management of hepatitis B and will cover topics
including HBV replication and mode of inducing chronicity; the immunology
of hepatitis B; virus-host interactions; the natural history of chronic
infection; and up-to-date results of trials of antiviral therapies. Participants
will discuss histological, clinical, and virological endpoints of therapy
and make recommendations on directions of future research. Sponsors of
the workshop include the National Institute of Diabetes and Digestive and
Kidney Diseases, part of the NIH; the American Association for the Study
of Liver Diseases; the American Liver Foundation; the Hepatitis B Foundation;
and Hepatitis Foundation International. |
| When: |
Thursday, April 6, 2006, 8:30 a.m. — 6:00 p.m.
Friday, April 7, 2006, 8:30 a.m. — 5:30 p.m.
Saturday, April 8, 2006, 8:30 a.m. — 12:00 p.m. |
| Where: |
Natcher Auditorium
Natcher Conference Center
NIH Campus
Bethesda, Maryland 20892
|
|
For more information about the workshop and to view the agenda, visit the workshop
website at http://www.niddk.nih.gov/fund/other/hbv2006/index.htm.
The National Institutes of Health (NIH) — The Nation's Medical Research
Agency — includes 27 Institutes and Centers and is a component of the
U.S. Department of Health and Human Services. It is the primary federal agency for
conducting and supporting basic, clinical and translational medical research, and
it investigates the causes, treatments, and cures for both common and rare diseases.
For more information about NIH and its programs, visit http://www.nih.gov.
|